10x Genomics (TXG) has partnered with Anthropic to enhance its single-cell and spatial biology analysis tools by integrating them into Claude for Life Sciences. This collaboration allows researchers to perform advanced analyses using natural language queries, making the technology more accessible and eliminating the need for computational expertise. The integration connects 10x Genomics’ Cloud Analysis platform with Anthropic’s Claude using the Model Context Protocol (MCP). Following this announcement, 10x Genomics’ stock surged over 9%, with a notable shift in retail sentiment from bearish to bullish on Stocktwits. The Claude platform enables researchers to conduct inquiries in plain English, streamlining processes from hypothesis generation to data interpretation. 10x Genomics aims to support discoveries in oncology, immunology, and neuroscience. With Q3 earnings expected in early November, analysts predict revenues between $140 million and $144 million. Stay updated for more insights on biotech advancements!
Source link
